Cargando…

Demographic and Clinical Predictors of Trait Impulsivity in Parkinson's Disease Patients

BACKGROUND: Impulsive behaviour has become increasingly recognised as a neuropsychiatric complication of Parkinson's disease (PD). Thought to be a product of compromised cognitive control, the spectrum of impulsive behaviours in PD ranges from cognitive disinhibition to impulse control disorder...

Descripción completa

Detalles Bibliográficos
Autores principales: Riley, Maddeson, Bakeberg, Megan, Byrnes, Michelle, Jefferson, Alexa, Ghosh, Soumya, Stell, Rick, Mastaglia, Frank L., Hince, Dana, Anderton, Ryan S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933009/
https://www.ncbi.nlm.nih.gov/pubmed/29850017
http://dx.doi.org/10.1155/2018/9472120
_version_ 1783319921370857472
author Riley, Maddeson
Bakeberg, Megan
Byrnes, Michelle
Jefferson, Alexa
Ghosh, Soumya
Stell, Rick
Mastaglia, Frank L.
Hince, Dana
Anderton, Ryan S.
author_facet Riley, Maddeson
Bakeberg, Megan
Byrnes, Michelle
Jefferson, Alexa
Ghosh, Soumya
Stell, Rick
Mastaglia, Frank L.
Hince, Dana
Anderton, Ryan S.
author_sort Riley, Maddeson
collection PubMed
description BACKGROUND: Impulsive behaviour has become increasingly recognised as a neuropsychiatric complication of Parkinson's disease (PD). Thought to be a product of compromised cognitive control, the spectrum of impulsive behaviours in PD ranges from cognitive disinhibition to impulse control disorders (ICDs). OBJECTIVE: At present, there are no indicators for trait impulsivity in PD. The objective of the current study was to identify demographic and clinical predictors of susceptibility to trait impulsivity in a cohort of PD patients. METHODS: The current study assessed impulsivity using the Barratt Impulsiveness Scale 11 (BIS-11) in a cohort of 87 PD patients. General linear models (GLMs) were used to identify clinical and demographic variables predictive of heightened BIS-11 second-order attentional and nonplanning subscale scores. RESULTS: Male gender, no history of smoking, postsecondary education, and heightened disease severity were predictive of increased BIS-11 attentional scores (p < 0.05). Similarly, male gender, after secondary education, and disease severity were predictive of increased BIS-11 nonplanning scores (p < 0.05). Contrary to previous reports, dopaminergic medication use was not a significant determinant of either BIS-11 subscale scores. CONCLUSIONS: Several demographic and clinical variables including male gender, no history of past smoking, after secondary education, and elevated disease severity are associated with impulsivity in PD.
format Online
Article
Text
id pubmed-5933009
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-59330092018-05-30 Demographic and Clinical Predictors of Trait Impulsivity in Parkinson's Disease Patients Riley, Maddeson Bakeberg, Megan Byrnes, Michelle Jefferson, Alexa Ghosh, Soumya Stell, Rick Mastaglia, Frank L. Hince, Dana Anderton, Ryan S. Parkinsons Dis Research Article BACKGROUND: Impulsive behaviour has become increasingly recognised as a neuropsychiatric complication of Parkinson's disease (PD). Thought to be a product of compromised cognitive control, the spectrum of impulsive behaviours in PD ranges from cognitive disinhibition to impulse control disorders (ICDs). OBJECTIVE: At present, there are no indicators for trait impulsivity in PD. The objective of the current study was to identify demographic and clinical predictors of susceptibility to trait impulsivity in a cohort of PD patients. METHODS: The current study assessed impulsivity using the Barratt Impulsiveness Scale 11 (BIS-11) in a cohort of 87 PD patients. General linear models (GLMs) were used to identify clinical and demographic variables predictive of heightened BIS-11 second-order attentional and nonplanning subscale scores. RESULTS: Male gender, no history of smoking, postsecondary education, and heightened disease severity were predictive of increased BIS-11 attentional scores (p < 0.05). Similarly, male gender, after secondary education, and disease severity were predictive of increased BIS-11 nonplanning scores (p < 0.05). Contrary to previous reports, dopaminergic medication use was not a significant determinant of either BIS-11 subscale scores. CONCLUSIONS: Several demographic and clinical variables including male gender, no history of past smoking, after secondary education, and elevated disease severity are associated with impulsivity in PD. Hindawi 2018-04-19 /pmc/articles/PMC5933009/ /pubmed/29850017 http://dx.doi.org/10.1155/2018/9472120 Text en Copyright © 2018 Maddeson Riley et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Riley, Maddeson
Bakeberg, Megan
Byrnes, Michelle
Jefferson, Alexa
Ghosh, Soumya
Stell, Rick
Mastaglia, Frank L.
Hince, Dana
Anderton, Ryan S.
Demographic and Clinical Predictors of Trait Impulsivity in Parkinson's Disease Patients
title Demographic and Clinical Predictors of Trait Impulsivity in Parkinson's Disease Patients
title_full Demographic and Clinical Predictors of Trait Impulsivity in Parkinson's Disease Patients
title_fullStr Demographic and Clinical Predictors of Trait Impulsivity in Parkinson's Disease Patients
title_full_unstemmed Demographic and Clinical Predictors of Trait Impulsivity in Parkinson's Disease Patients
title_short Demographic and Clinical Predictors of Trait Impulsivity in Parkinson's Disease Patients
title_sort demographic and clinical predictors of trait impulsivity in parkinson's disease patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933009/
https://www.ncbi.nlm.nih.gov/pubmed/29850017
http://dx.doi.org/10.1155/2018/9472120
work_keys_str_mv AT rileymaddeson demographicandclinicalpredictorsoftraitimpulsivityinparkinsonsdiseasepatients
AT bakebergmegan demographicandclinicalpredictorsoftraitimpulsivityinparkinsonsdiseasepatients
AT byrnesmichelle demographicandclinicalpredictorsoftraitimpulsivityinparkinsonsdiseasepatients
AT jeffersonalexa demographicandclinicalpredictorsoftraitimpulsivityinparkinsonsdiseasepatients
AT ghoshsoumya demographicandclinicalpredictorsoftraitimpulsivityinparkinsonsdiseasepatients
AT stellrick demographicandclinicalpredictorsoftraitimpulsivityinparkinsonsdiseasepatients
AT mastagliafrankl demographicandclinicalpredictorsoftraitimpulsivityinparkinsonsdiseasepatients
AT hincedana demographicandclinicalpredictorsoftraitimpulsivityinparkinsonsdiseasepatients
AT andertonryans demographicandclinicalpredictorsoftraitimpulsivityinparkinsonsdiseasepatients